Aurealis Therapeutics to participate in Biotech Week Boston and LSX World Congress USA

LEARN MORE
Linkedin-in Youtube

LSX World Congress USA 2025

  • Start: 16 September, 2025
  • End: 17 September, 2025
  • Location: Boston, USA

Aurealis Therapeutics will be attending LSX World Congress USA, 16-17 September 2025 in Boston. This is a leading forum that brings together innovators, investors, and senior life science dealmakers to shape the future of healthcare.

Representing Aurealis Therapeutics will be Juha Yrjänheikki (CEO) and Laurent Décory (COO). Our team will also present on Wednesday, 17 September at 12:45, highlighting our multi-target technology platform and latest clinical advancements from our pipeline.

🔗 Interested to hear more? Book a meeting with us! 

 

Share the event:

other recent events:

Partnering Week in China 2025

Aurealis Therapeutics team visited China from June 9–13, 2025, for a dedicated partnering week. Juha Yrjänheikki (CEO), Laurent Décory (COO), Hanna-Riikka Kärkkäinen (Director, Quality & Regulatory Affairs), and Jere Kurkipuro (Director, Pre-clinical & Pharmacology) met with investors, scientific partners, and licensing stakeholders to explore new collaboration opportunities.

Read More »

Swiss Biotech Day 2025

A premier global biotechnology conference for life sciences professionals, held in Basel, Switzerland May 5-6, 2025. Laurent Décory (COO) attended the event and participated in the Microbiome Innovators session.

Read More »

Baarerstrasse 21, CH-6300

Zug, Switzerland

Microkatu 1, FI-70210

Kuopio, Finland

Linkedin-in X-twitter Youtube Instagram

Join our newsletter:

This information will only be used to send you our newsletter. You can unsubscribe at any moment.

Ⓒ 2025 Aurealis Therapeutics. All Rights Reserved.